Completed PHASE3 INTERVENTIONAL 2-arm NCT00588133

A Preliminary Study of a New Tranexamic Acid Dosing Schedule for Cardiac Surgery

Sponsor: Mayo Clinic

Updated 5 times since 2017 Last updated: Nov 9, 2009 Started: Jan 31, 2004 Primary completion: Dec 31, 2007 Completion: Aug 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Cardiac Surgery, this trial is completed. The trial is conducted by Mayo Clinic and has accumulated 5 data snapshots since 2004. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jan 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mayo Clinic

Data source: Mayo Clinic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.